{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T09:26:10Z","timestamp":1770283570248,"version":"3.49.0"},"reference-count":105,"publisher":"Walter de Gruyter GmbH","issue":"5","license":[{"start":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T00:00:00Z","timestamp":1560988800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T00:00:00Z","timestamp":1560988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"crossref","award":["SCHU2951\/4-1"],"award-info":[{"award-number":["SCHU2951\/4-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00005-019-00551-8","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T07:38:02Z","timestamp":1561016282000},"page":"273-293","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Adjuvant Allergen Fusion Proteins as Novel Tools for the Treatment of Type I Allergies"],"prefix":"10.2478","volume":"67","author":[{"given":"Frank","family":"Blanco-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garibald","family":"Papp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Goretzki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Anzaghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9674-5116","authenticated-orcid":false,"given":"Stefan","family":"Sch\u00fclke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2019,6,20]]},"reference":[{"key":"551_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11882-018-0827-1","volume":"18","author":"M Anzaghe","year":"2018","unstructured":"Anzaghe M, Sch\u00fclke S, Scheurer S (2018) Virus-like particles as carrier systems to enhance immunomodulation in allergen immunotherapy. Curr Allergy Asthma Rep 18:71","journal-title":"Curr Allergy Asthma Rep"},{"key":"551_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.molimm.2017.02.005","volume":"85","author":"J Anzengruber","year":"2017","unstructured":"Anzengruber J, Bublin M, B\u00f6nisch E et al (2017) Lactobacillus buchneri S-layer as carrier for an Ara h 2-derived peptide for peanut allergen-specific immunotherapy. Mol Immunol 85:81\u201388","journal-title":"Mol Immunol"},{"key":"551_CR3","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3390\/toxins7030974","volume":"7","author":"KJ Baldauf","year":"2015","unstructured":"Baldauf KJ, Royal JM, Hamorsky KT et al (2015) Cholera toxin B: one subunit with many pharmaceutical applications. Toxins 7:974\u2013996","journal-title":"Toxins"},{"key":"551_CR4","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s40629-018-0069-8","volume":"27","author":"C Benito-Villalvilla","year":"2018","unstructured":"Benito-Villalvilla C, Soria I, Subiza JL et al (2018) Novel vaccines targeting dendritic cells by coupling allergoids to mannan. Allergo J Int 27:256\u2013262","journal-title":"Allergo J Int"},{"key":"551_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1046\/j.1365-2567.1998.00482.x","volume":"94","author":"TG Blanchard","year":"1998","unstructured":"Blanchard TG, Lycke N, Czinn SJ et al (1998) Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral immunization of mice against Helicobacter felis. Immunology 94:22\u201327","journal-title":"Immunology"},{"key":"551_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.molimm.2018.12.029","volume":"106","author":"F Blanco-P\u00e9rez","year":"2019","unstructured":"Blanco-P\u00e9rez F, Goretzki A, Wolfheimer S et al (2019) The vaccine adjuvant MPLA activates glycolytic metabolism in mouse mDC by a JNK-dependent activation of mTOR-signaling. Mol Immunol 106:159\u2013169","journal-title":"Mol Immunol"},{"key":"551_CR7","doi-asserted-by":"publisher","first-page":"6642","DOI":"10.4049\/jimmunol.172.11.6642","volume":"172","author":"B Bohle","year":"2004","unstructured":"Bohle B, Breitwieser A, Zw\u00f6lfer B et al (2004) A novel approach to specific allergy treatment: the recombinant fusion protein of a bacterial cell surface (S-layer) protein and the major birch pollen allergen Bet v 1 (rSbsC-Bet v 1) combines reduced allergenicity with immunomodulating capacity. J Immunol 172:6642\u20136648","journal-title":"J Immunol"},{"key":"551_CR8","first-page":"1","volume":"1","author":"P Bonanni","year":"2011","unstructured":"Bonanni P, Cheng WF, Cunningham A et al (2011) Article collection. Underst Mod Vaccines 1:1\u2013255","journal-title":"Underst Mod Vaccines"},{"key":"551_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/protein\/15.3.243","volume":"15","author":"A Breitwieser","year":"2002","unstructured":"Breitwieser A, Egelseer EM, Moll D et al (2002) A recombinant bacterial cell surface (S-layer)-major birch pollen allergen-fusion protein (rSbsC\/Bet v1) maintains the ability to self-assemble into regularly structured monomolecular lattices and the functionality of the allergen. Protein Eng 15:243\u2013249","journal-title":"Protein Eng"},{"key":"551_CR10","doi-asserted-by":"publisher","first-page":"8395","DOI":"10.1016\/j.vaccine.2007.10.003","volume":"25","author":"M Bublin","year":"2007","unstructured":"Bublin M, Hoflehner E, Wagner B et al (2007) Use of a genetic cholera toxin B subunit\/allergen fusion molecule as mucosal delivery system with immunosuppressive activity against Th2 immune responses. Vaccine 25:8395\u20138404","journal-title":"Vaccine"},{"key":"551_CR11","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1517\/14712598.7.10.1551","volume":"7","author":"P Chiarella","year":"2007","unstructured":"Chiarella P, Massi E, De Robertis M et al (2007) Adjuvants in vaccines and for immunisation: current trends. Expert Opin Biol Ther 7:1551\u20131562","journal-title":"Expert Opin Biol Ther"},{"key":"551_CR12","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1084\/jem.186.10.1623","volume":"186","author":"RS Chu","year":"1997","unstructured":"Chu RS, Targoni OS, Krieg AM et al (1997) CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med 186:1623\u20131631","journal-title":"J Exp Med"},{"key":"551_CR13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ebiom.2016.07.023","volume":"11","author":"C Cornelius","year":"2016","unstructured":"Cornelius C, Sch\u00f6neweis K, Georgi F et al (2016) Immunotherapy with the preS-based grass pollen allergy vaccine BM32 induces antibody responses protecting against hepatitis B infection. EBioMedicine 11:58\u201367","journal-title":"EBioMedicine"},{"key":"551_CR14","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.4049\/jimmunol.156.12.4570","volume":"156","author":"JS Cowdery","year":"1996","unstructured":"Cowdery JS, Chace JH, Yi AK et al (1996) Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides. J Immunol 156:4570\u20134575","journal-title":"J Immunol"},{"key":"551_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1398-9995.2006.01292.x","volume":"62","author":"R Crameri","year":"2007","unstructured":"Crameri R, Fl\u00fcckiger S, Daigle I et al (2007) Design, engineering and in vitro evaluation of MHC class-II targeting allergy vaccines. Allergy 62:197\u2013206","journal-title":"Allergy"},{"key":"551_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11882-018-0790-x","volume":"18","author":"M Curin","year":"2018","unstructured":"Curin M, Khaitov M, Karaulov A et al (2018) Next-generation of allergen-specific immunotherapies: molecular approaches. Curr Allergy Asthma Rep 18:39","journal-title":"Curr Allergy Asthma Rep"},{"key":"551_CR17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1749-6632.1996.tb21127.x","volume":"778","author":"C Czerkinsky","year":"1996","unstructured":"Czerkinsky C, Sun JB, Lebens M et al (1996) Cholera toxin B subunit as transmucosal carrier-delivery and immunomodulating system for induction of antiinfectious and antipathological immunity. Ann N Y Acad Sci 778:185\u2013193","journal-title":"Ann N Y Acad Sci"},{"key":"551_CR18","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3390\/vaccines3020320","volume":"3","author":"A Di Pasquale","year":"2015","unstructured":"Di Pasquale A, Preiss S, Tavares Da Silva F et al (2015) Vaccine adjuvants: from 1920 to 2015 and beyond. Vaccines 3:320\u2013343","journal-title":"Vaccines"},{"key":"551_CR19","doi-asserted-by":"publisher","first-page":"6298","DOI":"10.4049\/jimmunol.0713622","volume":"182","author":"J Edlmayr","year":"2009","unstructured":"Edlmayr J, Niespodziana K, Linhart B et al (2009) A combination vaccine for allergy and rhinovirus infections based on rhinovirus-derived surface protein VP1 and a nonallergenic peptide of the major timothy grass pollen allergen Phl p 1. J Immunol 182:6298\u20136306","journal-title":"J Immunol"},{"key":"551_CR20","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/nature06939","volume":"453","author":"SC Eisenbarth","year":"2008","unstructured":"Eisenbarth SC, Colegio OR, O\u2019Connor W et al (2008) Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453:1122\u20131126","journal-title":"Nature"},{"key":"551_CR21","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2217\/imt-2017-0163","volume":"10","author":"S Fanuel","year":"2018","unstructured":"Fanuel S, Tabesh S, Mokhtarian K et al (2018) Construction of a recombinant B-cell epitope vaccine based on a Der p1-derived hypoallergen: a bioinformatics approach. Immunotherapy 10:537\u2013553","journal-title":"Immunotherapy"},{"key":"551_CR22","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nri2888","volume":"11","author":"D Finlay","year":"2011","unstructured":"Finlay D, Cantrell DA (2011) Metabolism, migration and memory in cytotoxic T cells. Nat Rev Immunol 11:109\u2013117","journal-title":"Nat Rev Immunol"},{"issue":"1207\u20137","key":"551_CR23","first-page":"e1","volume":"135","author":"M Focke-Tejkl","year":"2015","unstructured":"Focke-Tejkl M, Weber M, Niespodziana K et al (2015) Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy. J Allergy Clin Immunol 135(1207\u20137):e1\u2013e11","journal-title":"J Allergy Clin Immunol"},{"key":"551_CR24","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/ni1346","volume":"7","author":"L Franchi","year":"2006","unstructured":"Franchi L, Amer A, Body-Malapel M et al (2006) Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat Immunol 7:576\u2013582","journal-title":"Nat Immunol"},{"key":"551_CR25","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.vetimm.2008.10.298","volume":"128","author":"S Garlapati","year":"2009","unstructured":"Garlapati S, Facci M, Polewicz M et al (2009) Strategies to link innate and adaptive immunity when designing vaccine adjuvants. Vet Immunol Immunopathol 128:184\u2013191","journal-title":"Vet Immunol Immunopathol"},{"key":"551_CR26","doi-asserted-by":"publisher","first-page":"7270","DOI":"10.4049\/jimmunol.179.11.7270","volume":"179","author":"M Gerstmayr","year":"2007","unstructured":"Gerstmayr M, Ilk N, Schabussova I et al (2007) A novel approach to specific allergy treatment: the recombinant allergen-S-layer fusion protein rSbsC-Bet v 1 matures dendritic cells that prime Th0\/Th1 and IL-10-producing regulatory T cells. J Immunol 179:7270\u20137275","journal-title":"J Immunol"},{"key":"551_CR27","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000199718","volume":"149","author":"M Gerstmayr","year":"2009","unstructured":"Gerstmayr M, Ilk N, Jahn-Schmid B et al (2009) Natural self-assembly of allergen-S-layer fusion proteins is no prerequisite for reduced allergenicity and T cell stimulatory capacity. Int Arch Allergy Immunol 149:231\u2013238","journal-title":"Int Arch Allergy Immunol"},{"key":"551_CR28","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1007\/s00253-013-5408-6","volume":"98","author":"L Guo","year":"2014","unstructured":"Guo L, Yin R, Liu K et al (2014) Immunological features and efficacy of a multi-epitope vaccine CTB-UE against H. pylori in BALB\/c mice model. Appl Microbiol Biotechnol 98:3495\u20133507","journal-title":"Appl Microbiol Biotechnol"},{"key":"551_CR29","doi-asserted-by":"publisher","first-page":"944","DOI":"10.4049\/jimmunol.164.2.944","volume":"164","author":"G Hartmann","year":"2000","unstructured":"Hartmann G, Krieg AM (2000) Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J Immunol 164:944\u2013953","journal-title":"J Immunol"},{"key":"551_CR30","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/35074106","volume":"410","author":"F Hayashi","year":"2001","unstructured":"Hayashi F, Smith KD, Ozinsky A et al (2001) The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410:1099\u20131103","journal-title":"Nature"},{"key":"551_CR31","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00705-010-0863-1","volume":"156","author":"PM Heegaard","year":"2011","unstructured":"Heegaard PM, Dedieu L, Johnson N et al (2011) Adjuvants and delivery systems in veterinary vaccinology: current state and future developments. Arch Virol 156:183\u2013202","journal-title":"Arch Virol"},{"key":"551_CR32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.pep.2015.02.001","volume":"109","author":"VV Hoang","year":"2015","unstructured":"Hoang VV, Zou Y, Kurata K et al (2015) Expression of recombinant T-cell epitopes of major Japanese cedar pollen allergens fused with cholera toxin B subunit in Escherichia coli. Protein Expr Purif 109:62\u201369","journal-title":"Protein Expr Purif"},{"key":"551_CR33","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.jaci.2005.10.043","volume":"117","author":"C Hoarau","year":"2006","unstructured":"Hoarau C, Lagaraine C, Martin L et al (2006) Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a Toll-like receptor 2 pathway. J Allergy Clin Immunol 117:696\u2013702","journal-title":"J Allergy Clin Immunol"},{"issue":"5 Suppl","key":"551_CR34","first-page":"42","volume":"50","author":"J Holmgren","year":"1994","unstructured":"Holmgren J, Czerkinsky C, Lycke N et al (1994) Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant. Am J Trop Med Hyg 50(5 Suppl):42\u201354","journal-title":"Am J Trop Med Hyg"},{"key":"551_CR35","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1128\/IAI.74.2.1113-1120.2006","volume":"74","author":"AN Honko","year":"2006","unstructured":"Honko AN, Sriranganathan N, Lees CJ et al (2006) Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis. Infect Immun 74:1113\u20131120","journal-title":"Infect Immun"},{"key":"551_CR36","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.vaccine.2006.08.013","volume":"25","author":"JW Huleatt","year":"2007","unstructured":"Huleatt JW, Jacobs AR, Tang J et al (2007) Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity. Vaccine 25:763\u2013775","journal-title":"Vaccine"},{"key":"551_CR37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1475-2859-10-6","volume":"10","author":"N Ilk","year":"2011","unstructured":"Ilk N, Schumi C-T, Bohle B et al (2011) Expression of an endotoxin-free S-layer\/allergen fusion protein in gram-positive Bacillus subtilis 1012 for the potential application as vaccines for immunotherapy of atopic allergy. Microb Cell Fact 10:6","journal-title":"Microb Cell Fact"},{"key":"551_CR38","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/1380-2933(96)00041-3","volume":"2","author":"B Jahn-Schmid","year":"1996","unstructured":"Jahn-Schmid B, Graninger M, Glozik M et al (1996) Immunoreactivity of allergen (Bet v 1) conjugated to crystalline bacterial cell surface layers (S-layers). Immunotechnology 2:103\u2013113","journal-title":"Immunotechnology"},{"key":"551_CR39","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1172\/JCI45416","volume":"121","author":"K Kastenm\u00fcller","year":"2011","unstructured":"Kastenm\u00fcller K, Wille-Reece U, Lindsay RW et al (2011) Protective T cell immunity in mice following protein-TLR7\/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets. J Clin Invest 121:1782\u20131796","journal-title":"J Clin Invest"},{"key":"551_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1443.020","volume":"1143","author":"T Kawai","year":"2008","unstructured":"Kawai T, Akira S (2008) Toll-like receptor and RIG-I-like receptor signaling. Ann N Y Acad Sci 1143:1\u201320","journal-title":"Ann N Y Acad Sci"},{"key":"551_CR41","doi-asserted-by":"publisher","first-page":"21145","DOI":"10.1074\/jbc.M701705200","volume":"282","author":"S Khan","year":"2007","unstructured":"Khan S, Bijker MS, Weterings JJ et al (2007) Distinct uptake mechanisms but similar intracellular processing of two different toll-like receptor ligand-peptide conjugates in dendritic cells. J Biol Chem 282:21145\u201321159","journal-title":"J Biol Chem"},{"key":"551_CR42","doi-asserted-by":"publisher","first-page":"293.e6","DOI":"10.1016\/j.jaci.2017.02.044","volume":"141","author":"C Kitzm\u00fcller","year":"2018","unstructured":"Kitzm\u00fcller C, Kalser J, Mutschlechner S et al (2018) Fusion proteins of flagellin and the major birch pollen allergen Bet v 1 show enhanced immunogenicity, reduced allergenicity, and intrinsic adjuvanticity. J Allergy Clin Immunol 141:293.e6\u2013299.e6","journal-title":"J Allergy Clin Immunol"},{"key":"551_CR43","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1007\/s00106-013-2761-9","volume":"61","author":"L Klimek","year":"2013","unstructured":"Klimek L, Willers J, Schendzielorz P et al (2013) Immunotherapy of allergic rhinitis without allergens? New options for immunomodulation by vaccination with virus-like particles and CpG motifs. HNO 61:826\u2013833","journal-title":"HNO"},{"key":"551_CR44","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S1074-7613(00)80087-4","volume":"11","author":"DM Klinman","year":"1999","unstructured":"Klinman DM, Verthelyi D, Takeshita F et al (1999) Immune recognition of foreign DNA: a cure for bioterrorism? Immunity 11:123\u2013129","journal-title":"Immunity"},{"key":"551_CR45","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/374546a0","volume":"374","author":"AM Krieg","year":"1995","unstructured":"Krieg AM, Yi AK, Matson S et al (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374:546\u2013549","journal-title":"Nature"},{"key":"551_CR46","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s40521-014-0038-5","volume":"2","author":"TM K\u00fcndig","year":"2015","unstructured":"K\u00fcndig TM, Klimek L, Schendzielorz P et al (2015) Is the allergen really needed in allergy immunotherapy? Curr Treat Options Allergy 2:72\u201382","journal-title":"Curr Treat Options Allergy"},{"key":"551_CR47","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1586\/14760584.6.5.673","volume":"6","author":"M Kwissa","year":"2007","unstructured":"Kwissa M, Kasturi SP, Pulendran B (2007) The science of adjuvants. Expert Rev Vaccines 6:673\u2013684","journal-title":"Expert Rev Vaccines"},{"key":"551_CR48","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3349\/ymj.2001.42.1.91","volume":"42","author":"BK Lee","year":"2001","unstructured":"Lee BK, Yoo YG, Lee WY et al (2001) Ovalbumin fused with diphtheria toxin protects mice from ovalbumin induced anaphylactic shock. Yonsei Med J 42:91\u2013105","journal-title":"Yonsei Med J"},{"key":"551_CR49","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1111\/j.1365-2222.2004.02077.x","volume":"34","author":"BK Lee","year":"2004","unstructured":"Lee BK, Yoo JE, Jang YS et al (2004) Allergen-specific immunosuppression by ovalbumin fused with diphtheria toxin in mice sensitized with albumins of different origin. Clin Exp Allergy 34:1642\u20131648","journal-title":"Clin Exp Allergy"},{"key":"551_CR50","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1128\/IAI.74.1.694-702.2006","volume":"74","author":"SE Lee","year":"2006","unstructured":"Lee SE, Kim SY, Jeong BC et al (2006) A bacterial flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant activity to induce protective immunity. Infect Immun 74:694\u2013702","journal-title":"Infect Immun"},{"issue":"Suppl 3","key":"551_CR51","doi-asserted-by":"publisher","first-page":"C25","DOI":"10.1016\/j.vaccine.2010.07.021","volume":"28","author":"G Leroux-Roels","year":"2010","unstructured":"Leroux-Roels G (2010) Unmet needs in modern vaccinology: adjuvants to improve the immune response. Vaccine 28(Suppl 3):C25\u2013C36","journal-title":"Vaccine"},{"key":"551_CR52","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s002810000017","volume":"22","author":"H Liang","year":"2000","unstructured":"Liang H, Lipsky PE (2000) The response of human B lymphocytes to oligodeoxynucleotides. Springer Semin Immunopathol 22:63\u201375","journal-title":"Springer Semin Immunopathol"},{"key":"551_CR53","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1172\/JCI118894","volume":"98","author":"H Liang","year":"1996","unstructured":"Liang H, Nishioka Y, Reich CF et al (1996) Activation of human B cells by phosphorothioate oligodeoxynucleotides. J Clin Invest 98:1119\u20131129","journal-title":"J Clin Invest"},{"key":"551_CR54","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1099\/00221287-76-2-417","volume":"76","author":"I L\u00f6nnroth","year":"1973","unstructured":"L\u00f6nnroth I, Holmgren J (1973) Subunit structure of cholera toxin. J Gen Microbiol 76:417\u2013427","journal-title":"J Gen Microbiol"},{"key":"551_CR55","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/S1359-6446(03)02864-2","volume":"8","author":"DJ Marciani","year":"2003","unstructured":"Marciani DJ (2003) Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity. Drug Discov Today 8:934\u2013943","journal-title":"Drug Discov Today"},{"key":"551_CR56","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1067\/mai.2001.116984","volume":"108","author":"JD Marshall","year":"2001","unstructured":"Marshall JD, Abtahi S, Eiden JJ et al (2001) Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes T(H)1 cytokine expression while downregulating T(H)2 cytokine expression in PBMCs from human patients with ragweed allergy. J Allergy Clin Immunol 108:191\u2013197","journal-title":"J Allergy Clin Immunol"},{"key":"551_CR57","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.4049\/jimmunol.1202441","volume":"190","author":"K Marth","year":"2013","unstructured":"Marth K, Breyer I, Focke-Tejkl M et al (2013) A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype. J Immunol 190:3068\u20133078","journal-title":"J Immunol"},{"key":"551_CR58","doi-asserted-by":"publisher","first-page":"172X","DOI":"10.1111\/j.1398-9995.2008.01812.x","volume":"64","author":"JM Martinez Gomez","year":"2009","unstructured":"Martinez Gomez JM, Johansen P, Rose H et al (2009) Targeting the MHC class II pathway of antigen presentation enhances immunogenicity and safety of allergen immunotherapy. Allergy 64:172X\u2013178X","journal-title":"Allergy"},{"key":"551_CR59","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.4049\/jimmunol.172.6.3712","volume":"172","author":"MG Netea","year":"2004","unstructured":"Netea MG, Sutmuller R, Hermann C et al (2004) Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J Immunol 172:3712\u20133718","journal-title":"J Immunol"},{"key":"551_CR60","doi-asserted-by":"publisher","first-page":"497.e9","DOI":"10.1016\/j.jaci.2017.09.052","volume":"142","author":"V Niederberger","year":"2018","unstructured":"Niederberger V, Neubauer A, Gevaert P et al (2018) Safety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32. J Allergy Clin Immunol 142:497.e9\u2013509.e9","journal-title":"J Allergy Clin Immunol"},{"key":"551_CR61","doi-asserted-by":"publisher","first-page":"1562.e6","DOI":"10.1016\/j.jaci.2011.02.004","volume":"127","author":"K Niespodziana","year":"2011","unstructured":"Niespodziana K, Focke-Tejkl M, Linhart B et al (2011) A hypoallergenic cat vaccine based on Fel d 1-derived peptides fused to hepatitis B PreS. J Allergy Clin Immunol 127:1562.e6\u20131570.e6","journal-title":"J Allergy Clin Immunol"},{"key":"551_CR62","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.anai.2017.11.001","volume":"120","author":"G Passalacqua","year":"2018","unstructured":"Passalacqua G, Bagnasco D, Ferrando M et al (2018) Current insights in allergen immunotherapy. Ann Allergy Asthma Immunol 120:152\u2013154","journal-title":"Ann Allergy Asthma Immunol"},{"key":"551_CR63","doi-asserted-by":"publisher","first-page":"879783","DOI":"10.1155\/2015\/879783","volume":"2015","author":"G Pelaia","year":"2015","unstructured":"Pelaia G, Vatrella A, Busceti MT et al (2015) Cellular mechanisms underlying eosinophilic and neutrophilic airway inflammation in asthma. Mediators Inflamm 2015:879783","journal-title":"Mediators Inflamm"},{"key":"551_CR64","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.autrev.2015.05.014","volume":"14","author":"P Pellegrino","year":"2015","unstructured":"Pellegrino P, Clementi E, Radice S (2015) On vaccine\u2019s adjuvants and autoimmunity: current evidence and future perspectives. Autoimmun Rev 14:880\u2013888","journal-title":"Autoimmun Rev"},{"key":"551_CR65","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/j.0818-9641.2004.01272.x","volume":"82","author":"N Petrovsky","year":"2004","unstructured":"Petrovsky N, Aguilar JC (2004) Vaccine adjuvants: current state and future trends. Immunol Cell Biol 82:488\u2013496","journal-title":"Immunol Cell Biol"},{"key":"551_CR66","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.5415\/apallergy.2018.8.e14","volume":"8","author":"M Rajakulendran","year":"2018","unstructured":"Rajakulendran M, Tham EH, Soh JY et al (2018) Novel strategies in immunotherapy for allergic diseases. Asia Pac Allergy 8:e14","journal-title":"Asia Pac Allergy"},{"key":"551_CR67","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.it.2008.09.006","volume":"30","author":"SG Reed","year":"2009","unstructured":"Reed SG, Bertholet S, Coler RN et al (2009) New horizons in adjuvants for vaccine development. Trends Immunol 30:23\u201332","journal-title":"Trends Immunol"},{"key":"551_CR68","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nm0897-849","volume":"3","author":"M Roman","year":"1997","unstructured":"Roman M, Martin-Orozco E, Goodman JS et al (1997) Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med 3:849\u2013854","journal-title":"Nat Med"},{"key":"551_CR69","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.intimp.2017.04.011","volume":"48","author":"F Salari","year":"2017","unstructured":"Salari F, Vahedi F, Varasteh AR et al (2017) Enhanced sublingual immunotherapy by TAT-fused recombinant allergen in a murine rhinitis model. Int Immunopharmacol 48:118\u2013125","journal-title":"Int Immunopharmacol"},{"key":"551_CR70","doi-asserted-by":"publisher","first-page":"6169","DOI":"10.4049\/jimmunol.179.9.6169","volume":"179","author":"RM Salazar-Gonzalez","year":"2007","unstructured":"Salazar-Gonzalez RM, Srinivasan A, Griffin A et al (2007) Salmonella flagellin induces bystander activation of splenic dendritic cells and hinders bacterial replication in vivo. J Immunol 179:6169\u20136175","journal-title":"J Immunol"},{"key":"551_CR71","first-page":"153","volume":"133","author":"J Sanchez","year":"2011","unstructured":"Sanchez J, Holmgren J (2011) Cholera toxin\u2014a foe & a friend. Indian J Med Res 133:153\u2013163","journal-title":"Indian J Med Res"},{"key":"551_CR72","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s00018-008-7496-5","volume":"65","author":"J S\u00e1nchez","year":"2008","unstructured":"S\u00e1nchez J, Holmgren J (2008) Cholera toxin structure, gene regulation and pathophysiological and immunological aspects. Cell Mol Life Sci 65:1347\u20131360","journal-title":"Cell Mol Life Sci"},{"key":"551_CR73","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1067\/mai.2002.122156","volume":"109","author":"JV Santeliz","year":"2002","unstructured":"Santeliz JV, Van Nest G, Traquina P et al (2002) Amb a 1-linked CpG oligodeoxynucleotides reverse established airway hyperresponsiveness in a murine model of asthma. J Allergy Clin Immunol 109:455\u2013462","journal-title":"J Allergy Clin Immunol"},{"key":"551_CR74","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1128\/JB.182.4.859-868.2000","volume":"182","author":"M S\u00e1ra","year":"2000","unstructured":"S\u00e1ra M, Sleytr UB (2000) S-Layer proteins. J Bacteriol 182:859\u2013868","journal-title":"J Bacteriol"},{"key":"551_CR75","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1089\/ard.1994.4.99","volume":"4","author":"UM Sarmiento","year":"1994","unstructured":"Sarmiento UM, Perez JR, Becker JM et al (1994) In vivo toxicological effects of rel A antisense phosphorothioates in CD-1 mice. Antisense Res Dev 4:99\u2013107","journal-title":"Antisense Res Dev"},{"key":"551_CR76","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.molimm.2010.07.006","volume":"48","author":"S Sch\u00fclke","year":"2010","unstructured":"Sch\u00fclke S, Waibler Z, Mende MS et al (2010) Fusion protein of TLR5-ligand and allergen potentiates activation and IL-10 secretion in murine myeloid DC. Mol Immunol 48:341\u2013350","journal-title":"Mol Immunol"},{"key":"551_CR77","doi-asserted-by":"publisher","first-page":"1340.e12","DOI":"10.1016\/j.jaci.2011.07.036","volume":"128","author":"S Sch\u00fclke","year":"2011","unstructured":"Sch\u00fclke S, Burggraf M, Waibler Z et al (2011) A fusion protein of flagellin and ovalbumin suppresses the TH2 response and prevents murine intestinal allergy. J Allergy Clin Immunol 128:1340.e12\u20131348.e12","journal-title":"J Allergy Clin Immunol"},{"key":"551_CR78","doi-asserted-by":"publisher","first-page":"e87822","DOI":"10.1371\/journal.pone.0087822","volume":"9","author":"S Sch\u00fclke","year":"2014","unstructured":"Sch\u00fclke S, Wolfheimer S, Gadermaier G et al (2014) Prevention of intestinal allergy in mice by rflaA: ova is associated with enforced antigen processing and TLR5-dependent IL-10 secretion by mDC. PLoS One 9:e87822","journal-title":"PLoS One"},{"key":"551_CR79","doi-asserted-by":"publisher","first-page":"4156456","DOI":"10.1155\/2016\/4156456","volume":"2016","author":"S Sch\u00fclke","year":"2016","unstructured":"Sch\u00fclke S, Vogel L, Junker AC et al (2016) A fusion protein consisting of the vaccine adjuvant monophosphoryl lipid a and the allergen ovalbumin boosts allergen-specific Th1, Th2, and Th17 responses in vitro. J Immunol Res 2016:4156456","journal-title":"J Immunol Res"},{"key":"551_CR80","doi-asserted-by":"publisher","first-page":"1786.e11","DOI":"10.1016\/j.jaci.2017.07.002","volume":"141","author":"S Sch\u00fclke","year":"2018","unstructured":"Sch\u00fclke S, Fiedler AH, Junker AC et al (2018a) Critical role of mammalian target of rapamycin for IL-10 dendritic cell induction by a flagellin A conjugate in preventing allergic sensitization. J Allergy Clin Immunol 141:1786.e11\u20131798.e11","journal-title":"J Allergy Clin Immunol"},{"key":"551_CR81","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1038\/s41598-018-20635-3","volume":"8","author":"S Sch\u00fclke","year":"2018","unstructured":"Sch\u00fclke S, Kuttich K, Wolfheimer S et al (2018b) Author Correction: conjugation of wild-type and hypoallergenic mugwort allergen Art v 1 to flagellin induces IL-10-DC and suppresses allergen-specific TH2-responses in vivo. Sci Rep 8:2745","journal-title":"Sci Rep"},{"key":"551_CR82","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.jaci.2012.02.026","volume":"129","author":"G Senti","year":"2012","unstructured":"Senti G, Crameri R, Kuster D et al (2012) Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections. J Allergy Clin Immunol 129:1290\u20131296","journal-title":"J Allergy Clin Immunol"},{"key":"551_CR83","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00262-012-1317-2","volume":"62","author":"NA Sheikh","year":"2013","unstructured":"Sheikh NA, Petrylak D, Kantoff PW et al (2013) Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer. Cancer Immunol Immunother 62:137\u2013147","journal-title":"Cancer Immunol Immunother"},{"key":"551_CR84","doi-asserted-by":"publisher","first-page":"5575","DOI":"10.4049\/jimmunol.164.11.5575","volume":"164","author":"H Shirota","year":"2000","unstructured":"Shirota H, Sano K, Kikuchi T et al (2000) Regulation of murine airway eosinophilia and Th2 cells by antigen-conjugated CpG oligodeoxynucleotides as a novel antigen-specific immunomodulator. J Immunol 164:5575\u20135582","journal-title":"J Immunol"},{"key":"551_CR85","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4049\/jimmunol.167.1.66","volume":"167","author":"H Shirota","year":"2001","unstructured":"Shirota H, Sano K, Hirasawa N et al (2001) Novel roles of CpG oligodeoxynucleotides as a leader for the sampling and presentation of CpG-tagged antigen by dendritic cells. J Immunol 167:66\u201374","journal-title":"J Immunol"},{"key":"551_CR86","doi-asserted-by":"publisher","first-page":"558.e11","DOI":"10.1016\/j.jaci.2016.02.029","volume":"138","author":"S Sirvent","year":"2016","unstructured":"Sirvent S, Soria I, Cirauqui C et al (2016) Novel vaccines targeting dendritic cells by coupling allergoids to nonoxidized mannan enhance allergen uptake and induce functional regulatory T cells through programmed death ligand 1. J Allergy Clin Immunol 138:558.e11\u2013567.e11","journal-title":"J Allergy Clin Immunol"},{"key":"551_CR87","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1002\/(SICI)1521-3773(19990419)38:8<1034::AID-ANIE1034>3.0.CO;2-#","volume":"38","author":"UB Sleytr","year":"1999","unstructured":"Sleytr UB, Messner P, Pum D et al (1999) Crystalline bacterial cell surface layers (s layers): from supramolecular cell structure to biomimetics and nanotechnology. Angew Chem Int Ed Engl 38:1034\u20131054","journal-title":"Angew Chem Int Ed Engl"},{"key":"551_CR88","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1742-4658.2006.05606.x","volume":"274","author":"UB Sleytr","year":"2007","unstructured":"Sleytr UB, Egelseer EM, Ilk N et al (2007a) S-layers as a basic building block in a molecular construction kit. FEBS J 274:323\u2013334","journal-title":"FEBS J"},{"key":"551_CR89","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1574-6968.2006.00573.x","volume":"267","author":"UB Sleytr","year":"2007","unstructured":"Sleytr UB, Huber C, Ilk N et al (2007b) S-layers as a tool kit for nanobiotechnological applications. FEMS Microbiol Lett 267:131\u2013144","journal-title":"FEMS Microbiol Lett"},{"key":"551_CR90","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/1574-6976.12063","volume":"38","author":"UB Sleytr","year":"2014","unstructured":"Sleytr UB, Schuster B, Egelseer EM et al (2014) S-layers: principles and applications. FEMS Microbiol Rev 38:823\u2013864","journal-title":"FEMS Microbiol Rev"},{"key":"551_CR91","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12896-015-0195-z","volume":"15","author":"L Song","year":"2015","unstructured":"Song L, Xiong D, Kang X et al (2015) An avian influenza A (H7N9) virus vaccine candidate based on the fusion protein of hemagglutinin globular head and Salmonella typhimurium flagellin. BMC Biotechnol 15:79","journal-title":"BMC Biotechnol"},{"key":"551_CR92","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/386336a0","volume":"386","author":"T Sparwasser","year":"1997","unstructured":"Sparwasser T, Miethke T, Lipford G et al (1997a) Bacterial DNA causes septic shock. Nature 386:336\u2013337","journal-title":"Nature"},{"key":"551_CR93","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1002\/eji.1830270712","volume":"27","author":"T Sparwasser","year":"1997","unstructured":"Sparwasser T, Miethke T, Lipford G et al (1997b) Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock. Eur J Immunol 27:1671\u20131679","journal-title":"Eur J Immunol"},{"key":"551_CR94","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11248-011-9518-6","volume":"21","author":"CF Su","year":"2012","unstructured":"Su CF, Kuo IC, Chen PW et al (2012) Characterization of an immunomodulatory Der p 2-FIP-fve fusion protein produced in transformed rice suspension cell culture. Transgenic Res 21:177\u2013192","journal-title":"Transgenic Res"},{"key":"551_CR95","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1398-9995.1996.tb02118.x","volume":"51","author":"K Sugimura","year":"1996","unstructured":"Sugimura K, Hashiguchi S, Takahashi Y et al (1996) Th1\/Th2 response profiles to the major allergens Cry j 1 and Cry j 2 of Japanese cedar pollen. Allergy 51:732\u2013740","journal-title":"Allergy"},{"key":"551_CR96","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1084\/jem.187.7.1145","volume":"187","author":"S Sun","year":"1998","unstructured":"Sun S, Kishimoto H, Sprent J (1998) DNA as an adjuvant: capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell responses to specific antigen. J Exp Med 187:1145\u20131150","journal-title":"J Exp Med"},{"key":"551_CR97","doi-asserted-by":"publisher","first-page":"6027","DOI":"10.1016\/j.vaccine.2008.09.019","volume":"26","author":"H Takagi","year":"2008","unstructured":"Takagi H, Hiroi T, Yang L et al (2008) Efficient induction of oral tolerance by fusing cholera toxin B subunit with allergen-specific T-cell epitopes accumulated in rice seed. Vaccine 26:6027\u20136030","journal-title":"Vaccine"},{"key":"551_CR98","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"O Takeuchi","year":"2010","unstructured":"Takeuchi O, Akira S (2010) Pattern recognition receptors and inflammation. Cell 140:805\u2013820","journal-title":"Cell"},{"issue":"1 Pt 1","key":"551_CR99","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1067\/mai.2000.107927","volume":"106","author":"H Tighe","year":"2000","unstructured":"Tighe H, Takabayashi K, Schwartz D et al (2000) Conjugation of immunostimulatory DNA to the short ragweed allergen Amb a 1 enhances its immunogenicity and reduces its allergenicity. J Allergy Clin Immunol 106(1 Pt 1):124\u2013134","journal-title":"J Allergy Clin Immunol"},{"key":"551_CR100","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.3390\/toxins6041397","volume":"6","author":"JK Tinker","year":"2014","unstructured":"Tinker JK, Yan J, Knippel RJ et al (2014) Immunogenicity of a West Nile virus DIII-cholera toxin A2\/B chimera after intranasal delivery. Toxins 6:1397\u20131418","journal-title":"Toxins"},{"key":"551_CR101","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1586\/17469872.3.2.151","volume":"3","author":"D Vidal","year":"2008","unstructured":"Vidal D, Alomar A (2008) Mode of action and clinical use of imiquimod. Expert Rev Dermatol 3:151\u2013159","journal-title":"Expert Rev Dermatol"},{"key":"551_CR102","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1128\/IAI.01491-07","volume":"76","author":"M Vijay-Kumar","year":"2008","unstructured":"Vijay-Kumar M, Aitken JD, Kumar A et al (2008) Toll-like receptor 5-deficient mice have dysregulated intestinal gene expression and nonspecific resistance to Salmonella-induced typhoid-like disease. Infect Immun 76:1276\u20131281","journal-title":"Infect Immun"},{"key":"551_CR103","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1111\/all.12461","volume":"69","author":"A Zaleska","year":"2014","unstructured":"Zaleska A, Eiwegger T, Soyer O et al (2014) Immune regulation by intralymphatic immunotherapy with modular allergen translocation MAT vaccine. Allergy 69:1162\u20131170","journal-title":"Allergy"},{"key":"551_CR104","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1006\/jmbi.1995.0456","volume":"251","author":"RG Zhang","year":"1995","unstructured":"Zhang RG, Scott DL, Westbrook ML et al (1995) The three-dimensional crystal structure of cholera toxin. J Mol Biol 251:563\u2013573","journal-title":"J Mol Biol"},{"key":"551_CR105","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ebiom.2016.08.022","volume":"11","author":"P Zieglmayer","year":"2016","unstructured":"Zieglmayer P, Focke-Tejkl M, Schmutz R et al (2016) Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy. EBioMedicine 11:43\u201357","journal-title":"EBioMedicine"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-019-00551-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00005-019-00551-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-019-00551-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:06:32Z","timestamp":1721433992000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00005-019-00551-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,20]]},"references-count":105,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["551"],"URL":"https:\/\/doi.org\/10.1007\/s00005-019-00551-8","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,20]]},"assertion":[{"value":"27 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest relevant to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights and informed consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}